Tommi Tervonen

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 19

Top Topics

Chronic Obstructive Pulmonary Disease

Antiplatelet Therapy

Drug Administration

Top Venues

Multiple sclerosis (Houndmills, Basingstoke, England)

Multiple sclerosis journal - experimental, translational and clinical

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Tommi Tervonen, Robert J Fox, Anne Brooks, Tatiana Sidorenko, Neli Boyanova, Bennett Levitan, Brian Hennessy, Andrea Phillips-Beyer
Treatment preferences in relation to fatigue of patients with relapsing multiple sclerosis: A discrete choice experiment. Multiple sclerosis journal - experimental, translational and clinical 9 (1) (2023)
Cathy Anne Pinto, Tommi Tervonen, Aura Cecilia Jimenez-Moreno, Bennett Levitan, Montse Soriano Gabarró, Cynthia J Girman, Josephine M Norquist, A Brett Hauber
Current Practices and Challenges When Submitting Patient Experience Data for Regulatory Decisions by the US Food and Drug Administration: An Industry Survey. The patient (2023)
Tommi Tervonen, Robert J Fox, Anne Brooks, Tatiana Sidorenko, Neli Boyanova, Bennett Levitan, Brian Hennessy, Andrea Phillips-Beyer
Treatment preferences in relation to fatigue of patients with relapsing multiple sclerosis: A discrete choice experiment. Multiple sclerosis journal - experimental, translational and clinical 9 (1) (2023)
Jaein Seo, Tommi Tervonen, Kaname Ueda, Dian Zhang, Daisuke Danno, Antje Tockhorn-Heidenreich
Discrete Choice Experiment to Understand Japanese Patients' and Physicians' Preferences for Preventive Treatments for Migraine. Neurology and therapy (2023)
Robert J Fox, Tommi Tervonen, Andrea Phillips-Beyer, Tatiana Sidorenko, Neli Boyanova, Anne Brooks, Brian Hennessy, Carol Jamieson, Bennett Levitan
The relevance of fatigue to relapse rate in multiple sclerosis: Applying patient preference data to the OPTIMUM trial. Multiple sclerosis (Houndmills, Basingstoke, England) 29 (3) (2022)
Robert J Fox, Tommi Tervonen, Andrea Phillips-Beyer, Tatiana Sidorenko, Neli Boyanova, Anne Brooks, Brian Hennessy, Carol Jamieson, Bennett Levitan
The relevance of fatigue to relapse rate in multiple sclerosis: Applying patient preference data to the OPTIMUM trial. Multiple sclerosis (Houndmills, Basingstoke, England) 29 (3) (2022)
Jonathan Mauer, Kristin Bullock, Stephen Watt, Ed Whalen, Leo Russo, Rod Junor, John D Markman, A Brett Hauber, Tommi Tervonen
Multimethod quantitative benefit-risk assessment of treatments for moderate-to-severe osteoarthritis. British journal of clinical pharmacology 88 (8) (2022)
Caitlin Thomas, Afaf Raibouaa, Andreas Wollenberg, Jean-Philippe Capron, Nicolas Krucien, Hayley Karn, Tommi Tervonen
Patient preferences for atopic dermatitis medications in the UK, France and Spain: a discrete choice experiment. BMJ open 12 (8) (2022)
Robert J Fox, Tommi Tervonen, Andrea Phillips-Beyer, Tatiana Sidorenko, Neli Boyanova, Anne Brooks, Brian Hennessy, Carol Jamieson, Bennett Levitan
The relevance of fatigue to relapse rate in multiple sclerosis: Applying patient preference data to the OPTIMUM trial. Multiple sclerosis (Houndmills, Basingstoke, England) (2022)
Robert J Fox, Tommi Tervonen, Andrea Phillips-Beyer, Tatiana Sidorenko, Neli Boyanova, Anne Brooks, Brian Hennessy, Carol Jamieson, Bennett Levitan
The relevance of fatigue to relapse rate in multiple sclerosis: Applying patient preference data to the OPTIMUM trial. Multiple sclerosis (Houndmills, Basingstoke, England) 29 (3) (2022)
Hannah Collacott, Dian Zhang, Sebastian Heidenreich, Tommi Tervonen
Correction to: A Systematic and Critical Review of Discrete Choice Experiments in Asthma and Chronic Obstructive Pulmonary Disease. The patient (2021)
Tommi Tervonen, Pareen Vora, Jaein Seo, Nicolas Krucien, Kevin Marsh, Raffaele De Caterina, Ulrike Wissinger, Montse Soriano Gabarró
Patient Preferences of Low-Dose Aspirin for Cardiovascular Disease and Colorectal Cancer Prevention in Italy: A Latent Class Analysis. The patient 14 (5) (2021)
Cathy Anne Pinto, Gin Nie Chua, John F P Bridges, Ella Brookes, Johanna Hyacinthe, Tommi Tervonen
Comparing Patient Preferences for Antithrombotic Treatment During the Acute and Chronic Phases of Myocardial Infarction: A Discrete-Choice Experiment. The patient (2021)
Hannah Collacott, Dian Zhang, Sebastian Heidenreich, Tommi Tervonen
A Systematic and Critical Review of Discrete Choice Experiments in Asthma and Chronic Obstructive Pulmonary Disease. The patient (2021)
Tommi Tervonen, Natalia Hawken, Nicola A Hanania, Fernando J Martinez, Sebastian Heidenreich, Ileen Gilbert
Maintenance inhaler therapy preferences of patients with asthma or chronic obstructive pulmonary disease: a discrete choice experiment. Thorax 75 (9) (2020)
Tommi Tervonen, Aura Cecilia Jimenez-Moreno, Nicolas Krucien, Heather Gelhorn, Kevin Marsh, Sebastian Heidenreich
Willingness to Wait for a Vaccine Against COVID-19: Results of a Preference Survey. The patient 14 (3) (2020)
Tommi Tervonen, Francesco Pignatti, Douwe Postmus
From Individual to Population Preferences: Comparison of Discrete Choice and Dirichlet Models for Treatment Benefit-Risk Tradeoffs. Medical decision making : an international journal of the Society for Medical Decision Making 39 (7) (2019)
Cathy Anne Pinto, Tommi Tervonen, Kevin Marsh, Dimitra Lambrelli, Anna Schultze, Andrew Tershakovec, Johanna Hyacinthe, Thibaud Prawitz, Tarek A Hammad
Personalized benefit-risk assessments combining clinical trial and real-world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapy. Pharmacoepidemiology and drug safety 28 (4) (2019)
Tommi Tervonen, Heather Gelhorn, Sumitra Sri Bhashyam, Jiat-Ling Poon, Katharine S Gries, Anne Rentz, Kevin Marsh
MCDA swing weighting and discrete choice experiments for elicitation of patient benefit-risk preferences: a critical assessment. Pharmacoepidemiology and drug safety 26 (12) (2017)